Repurposing the hypertension drug Guanabenz, GuanaRep aims to provide an affordable therapy for Vanishing White Matter, a rare neurological disease that mostly affects young children. Their research, led by Amsterdam UMC Professor Marjo van der Knaap, shows promising clinical results. GuanaRep focuses on making treatments accessible to patients worldwide.